Trial Profile
Gardasil vaccination as therapy in low grade cervical abnormalities
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 19 Sep 2007
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Therapeutic Use
- 22 Aug 2007 Status changed from initiated to recruiting
- 14 Aug 2007 New trial record.